Daga ranar 16 zuwa 17 ga watan Yuni, 2023, MedGence ta halarci taron bunkasa masana'antun kiwon lafiya mai inganci da taron koli karo na 8 na fasahar R&D na kasar Sin, wanda aka gudanar cikin nasara a birnin Chongqing.
An karrama MedGence a matsayin ɗayan "2023 Manyan Kamfanonin R&D CRO a China"!
Da farko, a bikin bude taron, an fitar da jerin jerin jerin jerin sunayen "2022 na Sin Pharmaceutical R&D Strength Ranking" kuma an karrama MedGence a matsayin daya daga cikin "2023 Top 20 Pharmaceutical CRO Enterprises in China"!
The "2023 Pharmaceutical CRO Enterprises a kasar Sin" kwamitin CRO Ranking Experts Reviews ya zaba bisa ga 10 Manuniya da mahara girma dabam, kamar shekara-shekara jimillar kudaden shiga (aiki kudaden shiga), shekara-shekara kudaden shiga (%), net riba, net riba girma (%), R&D zuba jari, R&D zuba jari (%), girman ma'aikata, girman girman ma'aikata (maki), da alama jagoranci (maki) da sauransu. TCM sabon kamfanin bunkasa magunguna, wanda ya lashe lambar yabo ta "2023 Top 20 Pharmaceutical CRO Enterprises in China", ya nuna iyawa da karfinsa.
A halin yanzu, a matsayinsa na shugaban TCM CXO, Dr. Yi Yueneng, shugaban kamfanin MedGence, da babban manajan MedGence, ya halarci taron koli na takwas na fasahar R&D na kasar Sin, kuma ya gabatar da jawabi mai taken "Farko daga karshe - dabarun raya sabbin magungunan kasar Sin". Ta yi nuni da cewa, a halin da ake ciki, an kara saurin tsara tsarin raya magungunan kasar Sin a mataki na farko, da inganta yanayin siyasa, da kara yawan tallafin da ake ba wa, kana likitan kasar Sin ya samar da wani zamani mai daraja. Har ila yau, ta tsara yanayin siyasa, da tsarin bincike da raya kasa, da yanayin aiwatar da bunkasuwar masana'antar likitancin gargajiya ta kasar Sin a sabon zamani, da nuna dangantakar da ke tsakaninta da ma'ana ta cikin gida, da yin nazari kan fitattun matsalolin da har yanzu ake samu a ci gaban masana'antar likitancin gargajiya ta kasar Sin a halin yanzu, da kuma gabatar da shawarwarin da za a iya magance su.
Sa'an nan, Dr. Yi Yueneng, a matsayin mai masaukin baki na dandalin tattaunawa mai taken "Shin bazarar sabuwar fasahar Sin tana zuwa", tare da 'yan wasan masana'antu sun tattauna kan al'amura da kalubalen da ake fuskanta a fannin kimiyyar kere-kere da fasahar kere-kere ta kasar Sin. A matsayinsa na babban mai shirya taron, MedGence ya kasance mai tushe a cikin masana'antar harhada magunguna, yana yin bincike sosai, da sabunta sabbin abubuwa, da inganta ci gaban masana'antu, da ci gaba da hidima ga kamfanonin harhada magunguna a duk fadin kasar Sin.
Taron ya jawo hankalin shugabanni da yawa a fannin ka'idojin harhada magunguna, kwalejoji da jami'o'i, cibiyoyin bincike, kamfanonin harhada magunguna, rukunin R & D da sauran masu fada aji da yawa don shiga cikin rahotannin jigo na R & D na likitancin gargajiya na kasar Sin, sabbin shirye-shirye, ka'idoji da manufofi, inganci da aminci, inganta aiwatarwa, sabbin kayan aiki, sabbin fasahohin zamani da sauran wuraren da za a yi taron koli, yayin taron koli guda daya. na masu baje kolin na musamman na taron, yana da rumfa na musamman, wanda ya jawo hankalin abokan aiki da yawa a cikin masana'antar don ziyarta! A yayin taron, a matsayin daya daga cikin masu baje kolin da aka gayyata, Enable Pharma yana da rumfa ta musamman, wacce ta jawo hankalin abokan aikin masana'antu da yawa don ziyartar rumfar don tuntubar juna, da kusanci da manyan kamfanonin harhada magunguna, da kuma dakile bukatar bincike da bunkasa magunguna.
Lokacin aikawa: Yuli-15-2023